Literature DB >> 16651451

Molecular evidence for independent origin of multifocal neuroendocrine tumors of the enteropancreatic axis.

Terrence M Katona1, Timothy D Jones, Mingsheng Wang, Fadi W Abdul-Karim, Oscar W Cummings, Liang Cheng.   

Abstract

Neuroendocrine tumors of the enteropancreatic axis are often multifocal. We have investigated whether multifocal intestinal carcinoid tumors and multifocal pancreatic endocrine tumors arise independently or whether they originate from a single clone with subsequent intramural or intrapancreatic spread. Twenty-four cases, including 16 multifocal intestinal carcinoid tumors and eight multifocal pancreatic endocrine tumors, were studied. Genomic DNA samples were prepared from 72 distinct tumor nodules using laser capture microdissection. Loss of heterozygosity (LOH) assays were done using markers for putative tumor suppressor genes located on chromosomes 9p21 (p16), 11q13 (MEN1), 11q23 (SDHD), 16q21, 18q21, and 18q22-23. In addition, X chromosome inactivation analysis was done on the tumors from eight female patients. Twenty-two of 24 (92%) cases showed allelic loss in at least one tumor focus, including 15 of 16 (94%) cases of multifocal carcinoid tumors and 7 of 8 (88%) cases of multifocal pancreatic endocrine tumors. Eleven of 24 (46%) cases exhibited a different LOH pattern for each tumor. Additionally, 9 of 24 (38%) cases showed different LOH patterns among some of the coexisting tumors, whereas other coexisting tumors displayed the same allelic loss pattern. Two of 24 (8%) cases showed the same LOH pattern in every individual tumor. X chromosome inactivation analysis showed a discordant pattern of nonrandom X chromosome inactivation in two of six informative cases and concordant pattern of nonrandom X chromosome inactivation in the four remaining informative cases. Our data suggest that some multifocal neuroendocrine tumors of the enteropancreatic axis arise independently, whereas others originate as a single clone with subsequent local and discontinuous metastasis.

Entities:  

Mesh:

Year:  2006        PMID: 16651451     DOI: 10.1158/0008-5472.CAN-05-4184

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Laser capture microdissection in the genomic and proteomic era: targeting the genetic basis of cancer.

Authors:  Barbara Domazet; Gregory T Maclennan; Antonio Lopez-Beltran; Rodolfo Montironi; Liang Cheng
Journal:  Int J Clin Exp Pathol       Date:  2008-03-15

2.  Role of Staging in Patients with Small Intestinal Neuroendocrine Tumours.

Authors:  Ashley Kieran Clift; Omar Faiz; Adil Al-Nahhas; Andreas Bockisch; Marc Olaf Liedke; Erik Schloericke; Harpreet Wasan; John Martin; Paul Ziprin; Krishna Moorthy; Andrea Frilling
Journal:  J Gastrointest Surg       Date:  2015-09-22       Impact factor: 3.452

Review 3.  Laser capture microdissection: Big data from small samples.

Authors:  Soma Datta; Lavina Malhotra; Ryan Dickerson; Scott Chaffee; Chandan K Sen; Sashwati Roy
Journal:  Histol Histopathol       Date:  2015-04-20       Impact factor: 2.303

4.  A pilot genome-wide association study shows genomic variants enriched in the non-tumor cells of patients with well-differentiated neuroendocrine tumors of the ileum.

Authors:  Kyle M Walsh; Murim Choi; Kjell Oberg; Matthew H Kulke; James C Yao; Chengqing Wu; Magdalena Jurkiewicz; Ling-I Hsu; Susanne M Hooshmand; Manal Hassan; Eva T Janson; Janet L Cunningham; Evan Vosburgh; Richard S Sackler; Richard P Lifton; Andrew T Dewan; Josephine Hoh
Journal:  Endocr Relat Cancer       Date:  2011-01-13       Impact factor: 5.678

5.  Is Multifocality an Indicator of Aggressive Behavior in Small Bowel Neuroendocrine Tumors?

Authors:  Allen B Choi; Jessica E Maxwell; Kendall J Keck; Andrew J Bellizzi; Joseph S Dillon; Thomas M OʼDorisio; James R Howe
Journal:  Pancreas       Date:  2017-10       Impact factor: 3.327

6.  Multifocality in Small Bowel Neuroendocrine Tumors.

Authors:  Alexandra Gangi; Emily Siegel; Galinos Barmparas; Simon Lo; Laith H Jamil; Andrew Hendifar; Nicholas N Nissen; Edward M Wolin; Farin Amersi
Journal:  J Gastrointest Surg       Date:  2017-11-08       Impact factor: 3.452

Review 7.  Gl-NETs-uniform but also diverse.

Authors:  Yogeshwar Dayal
Journal:  Endocr Pathol       Date:  2007       Impact factor: 3.943

8.  Searching for primaries in patients with neuroendocrine tumors (NET) of unknown primary and clinically suspected NET: Evaluation of Ga-68 DOTATOC PET/CT and In-111 DTPA octreotide SPECT/CT.

Authors:  Nils Friedemann Schreiter; Ann-Mirja Bartels; Vera Froeling; Ingo Steffen; Ulrich-Frank Pape; Alexander Beck; Bernd Hamm; Winfried Brenner; Rainer Röttgen
Journal:  Radiol Oncol       Date:  2014-11-05       Impact factor: 2.991

9.  Gene network-based analysis identifies two potential subtypes of small intestinal neuroendocrine tumors.

Authors:  Mark Kidd; Irvin M Modlin; Ignat Drozdov
Journal:  BMC Genomics       Date:  2014-07-15       Impact factor: 3.969

10.  Patterns of chromosome 18 loss of heterozygosity in multifocal ileal neuroendocrine tumors.

Authors:  Zhouwei Zhang; Netta Mäkinen; Yosuke Kasai; Grace E Kim; Begoña Diosdado; Eric Nakakura; Matthew Meyerson
Journal:  Genes Chromosomes Cancer       Date:  2020-04-27       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.